SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-19-178934
Filing Date
2019-06-21
Accepted
2019-06-21 17:04:10
Documents
6
Effectiveness Date
2019-06-21

Document Format Files

Seq Description Document Type Size
1 S-8 d740662ds8.htm S-8 51754
2 EX-4.7 d740662dex47.htm EX-4.7 198516
3 EX-5.1 d740662dex51.htm EX-5.1 8250
4 EX-23.1 d740662dex231.htm EX-23.1 1892
5 EX-23.2 d740662dex232.htm EX-23.2 2450
6 GRAPHIC g740662dsp001.jpg GRAPHIC 6562
  Complete submission text file 0001193125-19-178934.txt   273810
Mailing Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE, SUITE 200 SAN DIEGO CA 92121 858-900-2660
Arcturus Therapeutics Ltd. (Filer) CIK: 0001566049 (see all company filings)

IRS No.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-232272-01 | Film No.: 19912279
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121
Business Address 10628 SCIENCE CENTER DRIVE SUITE 250 SAN DIEGO CA 92121 8589002660
Arcturus Therapeutics Holdings Inc. (Filer) CIK: 0001768224 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-232272 | Film No.: 19912278
SIC: 2834 Pharmaceutical Preparations